ASCO® 2023 Insights: "Randomized, Double-Blind, Placebo-Controlled D-TORCH Study - Topical Diclofenac in Prevention of Hand-Foot Syndrome in Patients Receiving Capecitabine"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® 2023 Insights: "Randomized, Double-Blind, Placebo-Controlled D-TORCH Study - Topical Diclofenac in Prevention of Hand-Foot Syndrome in Patients Receiving Capecitabine"

By Insights from 2023 ASCO® Annual Meeting FEATURING Atul Batra

156 views

August 7, 2023

0 Comments

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, …

Feat. P. Tarantino

03:40

Integrity Continuing Education

SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & …

Feat. A. Bardia

14:16

Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino

17:20

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino

09:19

Insights from 2023 SABCS

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for…

Feat. K. Kalinsky

17:19

Moffitt Cancer Center

Year in Review: Colorectal Cancer

Feat. R. Kim, T. Biachi

22:55

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…

Feat. R. Kim, R. Mehta

04:28

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …

Feat. S. Tolaney

05:43

Total Health

Neoadjuvant Chemo for HR+ BC: Year in Review

Feat. C. Ma

27:37

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini

07:18

V.K. Gadi

The Role of ctDNA as a Surveillance Approach in HR+/HER2- eBC

30:46

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo

24:36

ESMO 2022 Conference Coverage

ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates

Feat. H. Rugo, J. O'Shaughnessy

23:58

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta

28:23

Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Anthracyclines for Early Stage Breast Cancer - Do They Still Have a …

Feat. V. Borges

20:07

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron

14:59

Insights from 2023 SABCS

SABCS 2023 Insights: "NRG Oncology/NSABP B-51/RTOG 1304 Trial -…

Feat. T. Mamounas

08:34

Yale Cancer Center

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Feat. J. Lacy

21:37

Dana-Farber Cancer Institute

Standard Treatments for HR+/HER2- mBC in 2023

Feat. S. Sammons

27:12

Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta

Login

Login

Join VuMedi

ASCO® 2023 Insights: "Randomized, Double-Blind, Placebo-Controlled D-TORCH Study - Topical Diclofenac in Prevention of Hand-Foot Syndrome in Patients Receiving Capecitabine"

Related Content